The estimated glomerular filtration rate predicts pacemaker-induced cardiomyopathy.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
02 10 2023
02 10 2023
Historique:
received:
19
06
2023
accepted:
30
09
2023
medline:
4
10
2023
pubmed:
3
10
2023
entrez:
2
10
2023
Statut:
epublish
Résumé
Clinical predictors for pacemaker-induced cardiomyopathy (PICM) (e.g., a wide QRS duration and left bundle branch block at baseline) have been reported. However, factors involved in the development of PICM in patients with preserved left ventricular ejection fraction (LVEF) remain unknown. This study aimed to determine the risk factors for PICM in patients with preserved LVEF. The data of 113 patients (average age: 71.3 years; men: 54.9%) who had echocardiography before and after pacemaker implantation (PMI) among 465 patients undergoing dual-chamber PMI were retrospectively analyzed. Thirty-three patients were diagnosed with PICM (18.0/100 person-years; 95% CI 12.8-25.2). A univariate Cox regression analysis showed that an estimated glomerular filtration rate (eGFR) ≤ 30 mL/min/1.73 m
Identifiants
pubmed: 37783787
doi: 10.1038/s41598-023-43953-7
pii: 10.1038/s41598-023-43953-7
pmc: PMC10545821
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
16514Informations de copyright
© 2023. Springer Nature Limited.
Références
Nielsen, J. C. et al. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: Echocardiographic and clinical outcome. J. Am. Coll. Cardiol. 42, 614–623 (2003).
doi: 10.1016/S0735-1097(03)00757-5
pubmed: 12932590
Kaye, G. et al. The prevalence of pacing-induced cardiomyopathy (PICM) in patients with long term right ventricular pacing—Is it a matter of definition?. Heart Lung Circ. 28, 1027–1033 (2019).
doi: 10.1016/j.hlc.2018.05.196
pubmed: 30017634
Gebauer, R. A. et al. Predictors of left ventricular remodelling and failure in right ventricular pacing in the young. Eur. Heart J. 30, 1097–1104 (2009).
doi: 10.1093/eurheartj/ehp060
pubmed: 19286675
pmcid: 2675702
Gillis, A. M. Optimal pacing for right ventricular and biventricular devices minimizing, maximizing, and right ventricular/left ventricular site considerations. Circulation 7, 968–977 (2014).
pubmed: 25336367
Bansal, R. et al. Incidence and predictors of pacemaker-induced cardiomyopathy with comparison between apical and non-apical right ventricular pacing sites. J. Interv. Cardiac Electrophysiol. 56, 63–70 (2019).
doi: 10.1007/s10840-019-00602-2
Merchant, F. M. & Mittal, S. Pacing-induced cardiomyopathy. Card. Electrophysiol Clin. 10, 437–445 (2018).
doi: 10.1016/j.ccep.2018.05.005
pubmed: 30172280
Khurshid, S. et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm. 11, 1619–1625 (2014).
doi: 10.1016/j.hrthm.2014.05.040
pubmed: 24893122
Kiehl, E. L. et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm. 13, 2272–2278 (2016).
doi: 10.1016/j.hrthm.2016.09.027
pubmed: 27855853
Lee, S. A. et al. Paced QRS duration and myocardial scar amount: Predictors of long-term outcome of right ventricular apical pacing. Heart Vessels 31, 1131–1139 (2016).
doi: 10.1007/s00380-015-0707-8
pubmed: 26142378
Yu, C. M. et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N. Engl. J. Med. 361, 2123–2134 (2009).
doi: 10.1056/NEJMoa0907555
pubmed: 19915220
Wakabayashi, Y. et al. Clinical characteristics associated with pacing-induced cardiac dysfunction: A high incidence of undiagnosed cardiac sarcoidosis before permanent pacemaker implantation. Heart Vessels 33, 1505–1514 (2018).
doi: 10.1007/s00380-018-1206-5
pubmed: 29931541
Mond, H. G. & Proclemer, A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: Calendar year 2009—A World Society of Arrhythmia’s project. Pacing Clin. Electrophysiol. 34, 1013–1027 (2011).
doi: 10.1111/j.1540-8159.2011.03150.x
pubmed: 21707667
Cho, S. W. et al. Clinical features, predictors, and long-term prognosis of pacing-induced cardiomyopathy. Eur. J. Heart Fail. 21, 643–651 (2019).
doi: 10.1002/ejhf.1427
pubmed: 30734436
Sharma, A. D. et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm. 2, 830–834 (2005).
doi: 10.1016/j.hrthm.2005.05.015
pubmed: 16051118
Curtis, A. B. et al. Improvement in clinical outcomes with biventricular versus right ventricular pacing: The BLOCK HF study. J. Am. Coll. Cardiol. 67, 2148–2157 (2016).
doi: 10.1016/j.jacc.2016.02.051
pubmed: 27151347
Kim, J. H. et al. Major determinant of the occurrence of pacing-induced cardiomyopathy in complete atrioventricular block: A multicentre, retrospective analysis over a 15-year period in South Korea. BMJ Open 8, e019048 (2018).
doi: 10.1136/bmjopen-2017-019048
pubmed: 29439074
pmcid: 5829811
Merchant, F. M. et al. Incidence and time course for developing heart failure with high-burden right ventricular pacing. Circ. Cardiovasc. Qual. Outcomes 10, e003564 (2017).
doi: 10.1161/CIRCOUTCOMES.117.003564
pubmed: 28630373
Merchant, F. M. & Mittal, S. Pacing induced cardiomyopathy. J. Cardiovasc. Electrophysiol. 31, 286–292 (2020).
doi: 10.1111/jce.14277
pubmed: 31724791
Matsuo, S. et al. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney Dis. 53, 982–992 (2009).
doi: 10.1053/j.ajkd.2008.12.034
pubmed: 19339088
Ebert, M. et al. Long-term impact of right ventricular pacing on left ventricular systolic function in pacemaker recipients with preserved ejection fraction: Results from a large single-center registry. J. Am. Heart Assoc. 5, e003485 (2016).
doi: 10.1161/JAHA.116.003485
pubmed: 27444509
pmcid: 5015385
Riahi, S. et al. Heart failure in patients with sick sinus syndrome treated with single lead atrial or dual-chamber pacing: No association with pacing mode or right ventricular pacing site. EP Europace 14, 1475–1482 (2012).
doi: 10.1093/europace/eus069
pubmed: 22447958
Tayal, B. et al. Incidence of heart failure after pacemaker implantation: A nationwide Danish Registry-based follow-up study. Eur. Heart J. 40, 3641–3648 (2019).
doi: 10.1093/eurheartj/ehz584
pubmed: 31504437
Abbas, J. et al. Incidence and predictors of pacemaker-induced cardiomyopathy with right ventricular pacing: A systematic review. Expert Rev. Cardiovasc. Ther. 20, 267–273 (2022).
doi: 10.1080/14779072.2022.2062323
pubmed: 35365062
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C.-Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296–1305 (2004).
doi: 10.1056/NEJMoa041031
pubmed: 15385656
Smith, G. L. et al. Renal impairment and outcomes in heart failure: Systematic review and meta-analysis. J. Am. Coll. Cardiol. 47, 1987–1996 (2006).
doi: 10.1016/j.jacc.2005.11.084
pubmed: 16697315
Kottgen, A. et al. Reduced kidney function as a risk factor for incident heart failure: The atherosclerosis risk in communities (ARIC) study. J. Am. Soc. Nephrol. 18, 1307–1315 (2007).
doi: 10.1681/ASN.2006101159
pubmed: 17344421
Zuchi, C. et al. Role of endothelial dysfunction in heart failure. Heart Fail. Rev. 25, 21–30 (2020).
doi: 10.1007/s10741-019-09881-3
pubmed: 31686283
Chen, J. et al. Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol. 2, 635–643 (2017).
doi: 10.1001/jamacardio.2017.0363
pubmed: 28329057
pmcid: 5798875
Karpawich, P. P., Justice, C. D., Cavitt, D. L. & Chang, C. H. Developmental sequelae of fixed-rate ventricular pacing in the immature canine heart: An electrophysiologic, hemodynamic, and histopathologic evaluation. Am Heart J. 119, 1077–1083 (1990).
doi: 10.1016/S0002-8703(05)80237-6
pubmed: 2139537
Prinzen, F. W., Augustijn, C. H., Arts, T., Allessie, M. A. & Reneman, R. S. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am. J. Physiol. 259, H300–H308 (1990).
pubmed: 2386214
Nielsen, J. C., Bottcher, M., Nielsen, T. T., Pedersen, A. K. & Andersen, H. R. Regional myocardial blood flow in patients with sick sinus syndrome randomized to long-term single chamber atrial or dual chamber pacing–effect of pacing mode and rate. J. Am. Coll. Cardiol. 35, 1453–1461 (2000).
doi: 10.1016/S0735-1097(00)00593-3
pubmed: 10807447
Lin, Y. S. et al. Liver X receptor/retinoid X receptor pathway plays a regulatory role in pacing‐induced cardiomyopathy. J. Am. Heart Assoc. 8, e009146 (2019).
doi: 10.1161/JAHA.118.009146
pubmed: 30612502
pmcid: 6405706
Lin, Y. S. et al. Statins to prevent pacing-induced cardiomyopathy: Evidence from the bench applied to clinical studies. Heart Rhythm 19, 960–968 (2022).
doi: 10.1016/j.hrthm.2022.01.029
pubmed: 35108621
Ruberg, F. L. Myocardial lipid accumulation in the diabetic heart. Circulation. 116, 1110–1112 (2007).
doi: 10.1161/CIRCULATIONAHA.107.721860
pubmed: 17768302